These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 10069951

  • 21. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
    Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, Diamond MS, Kuhn RJ, Rossmann MG.
    Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
    [Abstract] [Full Text] [Related]

  • 22. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N, Guichard G, Briand JP, Muller S, Brown F, Van Regenmortel MH.
    Dev Biol Stand; 1996 Mar; 87():283-91. PubMed ID: 8854029
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN, Parkhouse RM.
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
    Baranowski E, Ruiz-Jarabo CM, Lim F, Domingo E.
    Virology; 2001 Sep 30; 288(2):192-202. PubMed ID: 11601891
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.
    Yoon SK, Mohr L, O'Riordan CR, Lachapelle A, Armentano D, Wands JR.
    Biochem Biophys Res Commun; 2000 Jun 07; 272(2):497-504. PubMed ID: 10833442
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view.
    Thouvenin E, Schoehn G, Rey F, Petitpas I, Mathieu M, Vaney MC, Cohen J, Kohli E, Pothier P, Hewat E.
    J Mol Biol; 2001 Mar 16; 307(1):161-72. PubMed ID: 11243811
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity.
    Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D.
    Structure; 1996 Feb 15; 4(2):135-45. PubMed ID: 8805520
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mapping Antigenic Epitopes on the Human Bocavirus Capsid.
    Kailasan S, Garrison J, Ilyas M, Chipman P, McKenna R, Kantola K, Söderlund-Venermo M, Kučinskaitė-Kodzė I, Žvirblienė A, Agbandje-McKenna M.
    J Virol; 2016 May 15; 90(9):4670-4680. PubMed ID: 26912619
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Structure of human rhinovirus serotype 2 (HRV2).
    Verdaguer N, Blaas D, Fita I.
    J Mol Biol; 2000 Jul 28; 300(5):1179-94. PubMed ID: 10903863
    [Abstract] [Full Text] [Related]

  • 40. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS, Samuel AR, Pullen LA, Anderson J.
    Virology; 1998 Jul 20; 247(1):51-61. PubMed ID: 9683571
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.